Company Filing History:
2 out of 1,124 
Years Active: 2020
Title: Sungsin Jo: Innovator in Gene Therapy for Inflammatory Diseases
Introduction
Sungsin Jo is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of gene therapy, particularly in the prevention and treatment of inflammatory diseases. His innovative work has garnered attention in the scientific community.
Latest Patents
Sungsin Jo holds a patent for a gene/carrier complex designed to prevent or treat inflammatory diseases. This patent, which includes tumor necrosis factor-α converting enzyme (TACE) shRNA and a nonviral gene carrier, showcases his expertise in developing advanced therapeutic solutions. The nonviral gene carrier comprises an acetate of disulfide-linked poly(oligo-arginine) or a TFA salt of poly(oligo-aspartic acid)poly(oligo-arginine). He has 1 patent to his name.
Career Highlights
Sungsin Jo is affiliated with the Industry-University Cooperation Foundation at Hanyang University. His role in this institution allows him to bridge the gap between academic research and practical applications in the industry. His work is characterized by a commitment to advancing medical science through innovative solutions.
Collaborations
Throughout his career, Sungsin Jo has collaborated with notable colleagues, including Yong-Hee Kim and Tae-Hwan Kim. These partnerships have contributed to the development of groundbreaking research and advancements in gene therapy.
Conclusion
Sungsin Jo's contributions to the field of gene therapy highlight his dedication to addressing inflammatory diseases through innovative approaches. His work continues to inspire future research and development in this critical area of medicine.